Original price was: ₹400.00.₹378.00Current price is: ₹378.00.
| Specification | Details |
| Product Name | Empagliflozin, Sitagliptin & Metformin Tablets (25+100+100 mg) |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Strip with Box |
| Brand Name | Torso Empagliflozin, Sitagliptin & Metformin Tablets |
| Form | Tablet |
| Strength | 25+100+100 mg |
| Shelf Life | 24 Months |
| Usage | provides triple-action glycemic control by improving insulin sensitivity (Metformin), enhancing incretin effects (Sitagliptin), and promoting urinary glucose excretion (Empagliflozin) for type 2 diabetes management |
| Route of Administration | Oral |
| Storage | Store below 30°C, protect from light and moisture |
| Certification | WHO-GMP, ISO, DCGI |
| Supply & Export | Available for the domestic and international markets |
| Manufacturer Name | Torso Healthcare |
| Country of Origin | Baddi, Himachal Pradesh (Made in India) |
Description
Empagliflozin, Sitagliptin & Metformin Tablets (25+100+100 mg) are antidiabetic medications for treating type 2 diabetes. It is a combination of three medicines that help control blood sugar levels. Empagliflozin, Sitagliptin & Metformin Tablets (25+100+100 mg) should be taken under your doctor’s or healthcare professional’s proper guidance. Take this medication orally with a glass of water.
Benefits
- Treat Type 2 Diabetes.
- Control Blood Sugar Level.
Side Effects
- Anxiety
- Blurred Vision
- Chills
- Dizziness
- Fast Heartbeat
- Headache
Empagliflozin, Sitagliptin & Metformin Tablets (25+100+100 mg) Manufacturers in India
Empagliflozin, Sitagliptin & Metformin Tablets (25+100+100 mg) are antidiabetic medications for treating type 2 diabetes. It is a combination of three medicines that help control blood sugar levels.
Torso Healthcare is the leading manufacturer of Letrozole tablets IP 2.5 mg in India. The company is an ISO, WHO, and GMP-certified pharmaceutical manufacturer in India. We consistently deliver high-quality, reliable medicines by strictly adhering to standardized industry practices.





